Healthpeak Properties, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Healthpeak Properties, Inc. reports strong stockholder support for its Board of Directors, executive compensation, and auditor ratification at its 2026 Annual Meeting.
NYSE
Healthpeak Properties, Inc. secures a new $400 million delayed draw term loan and expands its existing term loan capacity to $2 billion, enhancing financial flexibility following the Janus IPO.
NYSE
Healthpeak Properties, Inc. announced its CEO, Scott Brinker, will present at the Citi 2026 Global Property CEO Conference on March 3, 2026.
NYSE
Healthpeak Properties reported fourth quarter and full-year 2025 financial results, alongside strategic updates including a planned senior housing REIT IPO and significant capital recycling initiatives.
NYSE
Healthpeak Properties reported third-quarter 2025 results, highlighting strong outpatient medical and CCRC performance, strategic asset sales, and an anticipated inflection point in the biopharma sector, despite a revised full-year earnings per share outlook.
NYSE
Healthpeak OP, a subsidiary of Healthpeak Properties, Inc., successfully completed an underwritten offering of $500 million in 4.750% senior notes due 2033, generating approximately $491.4 million in net proceeds for debt repayment and general corporate purposes.
NYSE
Healthpeak Properties' operating company priced a $500 million offering of 4.750% senior unsecured notes due 2033, with net proceeds aimed at debt repayment and general corporate purposes.
NYSE
Healthpeak Properties, Inc. has issued an updated and superseding discussion of its U.S. federal income tax considerations for its REIT status and securities.
NYSE
Healthpeak Properties, Inc. announced its second quarter 2025 financial results, revealing a significant drop in net income and a downward revision of full-year earnings guidance, despite robust operational metrics including strong same-store NOI growth and active leasing.
NYSE
Healthpeak Properties' Vice Chair, John Thomas, will participate in a panel discussion at the BofA Securities 2025 Healthcare Conference on May 14, 2025.
NYSE
Healthpeak Properties, Inc. announces the adoption of an Employee Stock Purchase Plan (ESPP) after receiving stockholder approval at its annual meeting.
NYSE
Healthpeak Properties announces positive Q1 2025 financial results, highlighted by a 7.0% increase in Total Same-Store Portfolio Cash (Adjusted) NOI growth.
NYSE
Healthpeak Properties names Kelvin Moses as its new Chief Financial Officer, effective immediately, as part of the company's succession plan.
NYSE
Peter Scott, CFO of Healthpeak Properties, has resigned to become CEO of Healthcare Realty Trust Incorporated.
NYSE
Healthpeak Properties' CEO, Scott Brinker, will present at the Citi 2025 Global Property CEO Conference on March 3, 2025.
NYSE
Healthpeak Properties' subsidiary, Healthpeak OP, LLC, successfully closed a $500 million offering of 5.375% senior notes due in 2035.
NYSE
Healthpeak Properties, Inc. announces the pricing of a $500 million public offering of 5.375% senior unsecured notes due 2035 through its operating company, Healthpeak OP, LLC.
NYSE
Healthpeak Properties' Chief Operating Officer, Thomas Klaritch, will retire in phases, stepping down from his COO role on March 1, 2025, and concluding his employment on September 30, 2025, followed by a consulting period.
NYSE
Healthpeak Properties announces positive Q4 and full-year 2024 results, including a dividend increase and significant leasing activity.
NYSE
Healthpeak Properties, Inc. has successfully amended and extended its $3 billion senior unsecured revolving credit facility, demonstrating strong lender support and bolstering its financial flexibility.
NYSE
Healthpeak Properties has increased its full-year 2024 guidance, driven by strong leasing activity, merger synergies, and property management internalization.
NYSE
Healthpeak Properties showcases robust earnings growth, strategic asset dispositions, and successful leasing activity in its latest investor presentation.
NYSE
Healthpeak Properties reported strong third-quarter 2024 results, driven by robust leasing activity and merger synergies, leading to an increase in full-year guidance.
NYSE
Healthpeak Properties reported strong second-quarter results, exceeding expectations and raising its full-year 2024 guidance across key financial metrics.
NYSE
Healthpeak Properties finalized its merger with Physicians Realty Trust on March 1, 2024, and has released pro forma financial statements reflecting the combined entity's performance.
NYSE
Healthpeak Properties reports the retirement of two directors, a reduction in board size, and the results of its 2024 annual meeting, including the election of eleven directors and approval of executive compensation and auditor ratification.
NYSE
Healthpeak Properties announced positive first quarter 2024 results, including a 4.5% growth in same-store cash NOI and increased full-year earnings guidance.
NYSE
Healthpeak Properties has filed a prospectus supplement for the resale of up to 6,546,873 shares of its common stock, which may be issued upon the exchange of non-managing member units of DOC DR, LLC.
NYSE
Healthpeak Properties has amended its at-the-market equity offering sales agreement, adding new sales agents and forward purchasers while removing others, to facilitate the potential sale of up to $1.5 billion in common stock.
NYSE
Healthpeak Properties reports strong 2023 performance, exceeding guidance, and details strategic benefits following its merger with Physicians Realty Trust.